To define the prognostic significance of PSG9 expression in breast cancer patients, we then performed IHC staining of PSG9 in 161 surgical specimens from patients diagnosed with invasive breast cancer with an anti‐PSG9 antibody. This evidence concerns the gene PSG9 and breast carcinoma.